The FDA is prioritizing listening to patients by approving treatments quickly — and in spite of the insurer backlash against accelerated approvals, writes Zachary Predmore. So why are health insurers standing in the way? https://t.co/eb2LhBJhHi
Hi Twitter! I’m Zach, a health policy researcher at RAND. One of my New Year’s resolutions is to tweet, so I’m activating this account! I’ll be tweeting about health tech, improving value of health care delivery, and getting patients more involved in health care.
Happy to share a pair of papers from @bwhdermatology @BrighamWomens led by @harvardmed student @SeanBSinger using the @CDCgov BRFSS database to evaluate skin cancer risk in #LGBT population. Both published today in @JAMADerm https://t.co/hCaZcB4AiV & https://t.co/RQIjkpp0KJ
Yes! Fourth star. Back to back. Congrats to the record breakers on the @USWNT, an incredible team that’s always pushing themselves—and the rest of us—to be even better. Love this team. #OneNationOneTeam
Today starts #HispanicHeritageMonth. When #skincancer develops in people with darker skin, it is often diagnosed at a later stage. Hear Noe tell his story about his skin cancer diagnosis and treatment. https://t.co/bbr4yYbb2e
Why are we talking about Hillary Clinton when 10 of my classmates and teachers died 2 days ago? Will we be forgotten about in a matter of days? Where is our support you promised? https://t.co/vLwmBNNyq7
An ever-growing body of research consistently reaches the same conclusion: The only variable that can explain the high rate of mass shootings in America is its astronomical number of guns https://t.co/tH1B5vqaJ5